The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Exclusively targeting β-secretase to lipid rafts by GPI-anchor addition up-regulates β-site processing of the amyloid precursor protein
Open accessAbstract
β-Secretase (BACE, Asp-2) is a transmembrane aspartic proteinase responsible for cleaving the amyloid precursor protein (APP) to generate the soluble ectodomain sAPPβ and its C-terminal fragment CTFβ. CTFβ is subsequently cleaved by γ-secretase to produce the neurotoxic/synaptotoxic amyloid-β peptide (Aβ) that accumulates in Alzheimer's disease. Indirect evidence has suggested that amyloidogenic APP processing may preferentially occur in lipid rafts. Here, we show that relatively little wild-type BACE is found in rafts prepared from a human neuroblastoma cell line (SH-SY5Y) by using Triton X-100 as detergent. To investigate further the significance of lipid rafts in APP processing, a glycosylphosphatidylinositol (GPI) anchor has been added to BACE, replacing the transmembrane and C-terminal domains. The GPI anchor targets the enzyme exclusively to lipid raft domains. Expression of GPIBACE substantially up-regulates the secretion of both sAPPβ and amyloid-β peptide over levels observed from cells overexpressing wild-type BACE. This effect was reversed when the lipid rafts were disrupted by depleting cellular cholesterol levels. These results suggest that processing of APP to the amyloid-β peptide occurs predominantly in lipid rafts and that BACE is the rate-limiting enzyme in this process. The processing of the APP 695 isoform by GPI-BACE was up-regulated 20-fold compared with wild-type BACE, whereas only a 2-fold increase in the processing of APP 751/770 was seen, implying a differential compartmentation of the APP isoforms. Changes in the local membrane environment during aging may facilitate the cosegregation of APP and BACE leading to increased β-amyloid production.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“APOE isoforms likely influence Aβ production by modulating lipid metabolism and the lipid composition of cellular membranes, with APOE4 promoting amyloidogenic APP cleavage and Aβ production more than APOE3 [8–10].”
In the citing paper
“APOE modulates APP metabolism in an isoform-dependent manner through distinct mechanisms: 1) influencing APP processing via effects on lipid metabolism [8–10], and 2) modulating Aβ clearance and aggregation via the formation of APOE-Aβ complexes [11, 12].”
In the citing paper
“Aβ peptides are produced primarily by neurons via the sequential cleavage of amyloid precursor protein (APP) by β- and γ-secretases (amyloidogenic pathway) at lipid rafts in the plasma membrane (PM) [35–37].”
From Inhibition of ACAT as a Therapeutic Target for Alzheimer's Disease Is Independent of ApoE4 Lipidation (2023) · cites this paper as [36]
Citations
Cites
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Lipid rafts and signal transduction
Simons, K., & Toomre, D. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35036052 · Cited by 5,371
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876
Brown, D. A., & Rose, J. K. (1992) · Cell · doi:10.1016/0092-8674(92)90189-j · Cited by 2,921
Statins and the risk of dementia
Jick, H., Zornberg, G. L., Jick, S. S., Seshadri, S. S., & Drachman, D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03155-x · Cited by 1,764
Purification and cloning of amyloid precursor protein β-secretase from human brain
Sinha, S., Anderson, J. P., Barbour, R., Basi, G. S., Caccavello, R., Davis, D., Doan, M., Dovey, H. F., Frigon, N., Hong, J., et al. (1999) · Nature · doi:10.1038/990114 · Cited by 1,612
Wolozin, B. L. (2000) · Archives of Neurology · doi:10.1001/archneur.57.10.1439 · Cited by 1,408
Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons
Simons, M., Keller, P., Strooper, B. D., Beyreuther, K. T., Dotti, C. G., & Simons, K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6460 · Cited by 1,177
Tanzi, R. E., McClatchey, A. I., Lamperti, E. D., Villa‐Komaroff, L., Gusella, J. F., & Neve, R. L. (1988) · Nature · doi:10.1038/331528a0 · Cited by 1,093
Flagged first, then by citations
Research works printed but not linked: 1
- Refolo, L. M., Malester, B., LaFrancois, J., Bryant-Thomas, T., Wang, R., Tint, G. S., Sambamurti, K., Duff, K. & Pappolla, M. A. (2000) Neurobiol. Dis. 4, 321–331.
Cited by
Sorted by citations
Items 101–200 of 354
Jiang, L., Tang, S., Wang, X., Liu, L., Long, Y., Hu, M. Y., Liao, M. X., Qi-long, D., Hu, W. M., Li, J., et al. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2012.00341.x · Cited by 96
BACE1 Structure and Function in Health and Alzheimers Disease
Cole, S., & Vassar, R. (2008) · Current Alzheimer Research · doi:10.2174/156720508783954758 · Cited by 98
Nuclear signalling by membrane protein intracellular domains: The AICD enigma
Beckett, C., Nalivaeva, N. N., Belyaev, N. D., & Turner, A. J. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.10.007 · Cited by 101
Self-citationHook, G., Reinheckel, T., Ni, J., Wu, Z., Kindy, M. S., Peters, C., & HOOK, V. Y. H. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000527 · Cited by 98
Cholesterol as a key player in amyloid β-mediated toxicity in Alzheimer’s disease
Rudajev, V., & Novotny, J. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.937056 · Cited by 94
Role of amyloid beta in lipid homeostasis
Grösgen, S., Grimm, M. O. W., Frieß, P., & Hartmann, T. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.05.002 · Cited by 90
Cholesterol, statins and dementia
Wolozin, B. L. (2004) · Current Opinion in Lipidology · doi:10.1097/00041433-200412000-00007 · Cited by 92
β‐Site APP‐cleaving enzyme 1 trafficking and Alzheimer’s disease pathogenesis
Tan, J., & Evin, G. M. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07623.x · Cited by 90
Klingenstein, R., Löber, S., Kujala, P., Godsave, S. F., Leliveld, S. R., Gmeiner, P., Peters, P. J., & Korth, C. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03889.x · Cited by 86
Function, regulation and therapeutic properties of β-secretase (BACE1)
Willem, M., Lammich, S., & Haass, C. (2009) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2009.01.003 · Cited by 87
Trafficking, a key player in regulated intramembrane proteolysis
Sannerud, R., & Annaert, W. G. (2008) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2008.11.004 · Cited by 86
Targeting Amyloid‐Degrading Enzymes as Therapeutic Strategies in Neurodegeneration
Turner, A. J., Fisk, L., & Nalivaeva, N. N. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1332.001 · Cited by 86
Self-citationPrion protein and Alzheimer disease
Kellett, K. A. B., & Hooper, N. M. (2009) · Prion · doi:10.4161/pri.3.4.9980 · Cited by 88
Self-citationThe Impact of Cholesterol, DHA, and Sphingolipids on Alzheimer’s Disease
Grimm, M. O. W., Zimmer, V. C., Lehmann, J., Grimm, H. S., & Hartmann, T. (2013) · BioMed Research International · doi:10.1155/2013/814390 · Cited by 85
Aβ–ganglioside interactions in the pathogenesis of Alzheimer's disease
Matsuzaki, K. (2020) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2020.183233 · Cited by 82
Cholesterol imbalance and neurotransmission defects in neurodegeneration
Shin, K. C., Moussa, H. Y. A., & Park, Y. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01273-4 · Cited by 87
Understanding BACE1: essential protease for amyloid-β production in Alzheimer’s disease
Stockley, J. H., & O’Neill, C. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8271-3 · Cited by 85
Cecchi, C., Nichino, D., Zampagni, M., Bernacchioni, C., Evangelisti, E., Pensalfini, A., Liguri, G., Gliozzi, A., Stefani, M., & Relini, A. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2009.07.019 · Cited by 82
Identification and biology of β‐secretase
Kandalepas, P. C., & Vassar, R. J. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07512.x · Cited by 83
Lakshmana, M. K., Yoon, I., Chen, E., Bianchi, E., Koo, E. H., & Kang, D. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807345200 · Cited by 79
EpCAM proteolysis: new fragments with distinct functions?
Schnell, U., Kuipers, J., & Giepmans, B. N. G. (2013) · Bioscience Reports · doi:10.1042/bsr20120128 · Cited by 79
γ-Secretase-dependent amyloid-β is increased in Niemann-Pick type C
Mattsson, N., Zetterberg, H., Bianconi, S. E., Yanjanin, N. M., Fu, R., Månsson, J., Porter, F. D., & Blennow, K. (2010) · Neurology · doi:10.1212/wnl.0b013e318208f4ab · Cited by 83
Popp, J., Lewczuk, P., Kölsch, H., Meichsner, S., Maier, W., Kornhuber, J., Jessen, F., & Lütjohann, D. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07893.x · Cited by 81
Using model membranes for the study of amyloid beta:lipid interactions and neurotoxicity
Vestergaard, M. C. M., Hamada, T., & Takagi, M. (2007) · Biotechnology and Bioengineering · doi:10.1002/bit.21731 · Cited by 79
Modificomics: Posttranslational modifications beyond protein phosphorylation and glycosylation
Reinders, J., & Sickmann, A. (2007) · Biomolecular Engineering · doi:10.1016/j.bioeng.2007.03.002 · Cited by 77
Amyloid beta as a regulator of lipid homeostasis
Grimm, M. O. W., Grimm, H. S., & Hartmann, T. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.06.004 · Cited by 78
Yoon, I., Chen, E., Busse, T., Repetto, E., Lakshmana, M. K., Koo, E. H., & Kang, D. E. (2007) · The FASEB Journal · doi:10.1096/fj.07-8114com · Cited by 79
Cross-talk of membrane lipids and Alzheimer-related proteins
Walter, J., & van Echten‐Deckert, G. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-34 · Cited by 79
Amyloid excess in Alzheimer's disease: What is cholesterol to be blamed for?
Ledesma, M. D., & Dotti, C. G. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.06.038 · Cited by 80
Human BACE Forms Dimers and Colocalizes with APP
Schmechel, A., Strauß, M., Schlicksupp, A., Pipkorn, R., Haass, C., Bayer, T. A., & Multhaup, G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402785200 · Cited by 77
Oxidative stress up-regulates presenilin 1 in lipid rafts in neuronal cells
Oda, A., Tamaoka, A., & Araki, W. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22271 · Cited by 76
Proteomic Identification of Lower Apolipoprotein A-I in Alzheimer’s Disease
Liu, H., Hu, C., Chang, J., Sung, S., Lee, L.-S., Yuan, R.-Y., & Leu, S. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000090676 · Cited by 75
HIV-1 Tat Interacts with and Regulates the Localization and Processing of Amyloid Precursor Protein
Kim, J., Yoon, J., & Kim, Y.-S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077972 · Cited by 76
Cell biology, regulation and inhibition of β‐secretase (BACE‐1)
Hunt, C. E., & Turner, A. J. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.06929.x · Cited by 78
Self-citationA disintegrin and metalloproteinase (ADAM)‐mediated ectodomain shedding of ADAM10
Parkin, E. T., & Harris, B. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05907.x · Cited by 72
MicroRNA in Alzheimer’s disease revisited: implications for major neuropathological mechanisms
Dehghani, R., Rahmani, F., & Rezaei, N. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0042 · Cited by 72
Inhibition of BACE1 for therapeutic use in Alzheimer's disease.
Luo, X., & Yan, R. (2010) · Europe PMC (PubMed Central) · Cited by 71
Berrocal, M., Marcos, D., Sepúlveda, M. R., Pérez, M., Ávila, J., & Mata, A. M. (2009) · The FASEB Journal · doi:10.1096/fj.08-121459 · Cited by 71
Zandl‐Lang, M., Fanaee‐Danesh, E., Sun, Y., Albrecher, N. M., Gali, C. C., Čančar, I., Kober, A. C., Tam‐Amersdorfer, C., Stracke, A., Storck, S. E., et al. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.09.008 · Cited by 73
Fuentealba, R. A., Barría, M. I., Lee, J., Cam, J., Araya, C., Escudero, C. A., Inestrosa, N. C., Bronfman, F. C., Bu, G., & Marzolo, M.-P. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-14 · Cited by 70
Guardia‐Laguarta, C., Coma, M., Pera, M., Clarimón, J., Sereno, L., Agullo, J. M., Molina‐Porcel, L., Gallardo, E., Deng, A., Berezovska, O., et al. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06126.x · Cited by 70
New Insights into the Roles of Metalloproteinases in Neurodegeneration and Neuroprotection
Turner, A. J., & Nalivaeva, N. N. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(07)82006-x · Cited by 71
Self-citationDown-regulation of Endogenous Amyloid Precursor Protein Processing due to Cellular Aging
Kern, A., Roempp, B., Prager, K., Walter, J., & Behl, C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505625200 · Cited by 69
Katafuchi, T., Ifuku, M., Mawatari, S., Noda, M., Miake, K., Sugiyama, M., & Fujino, T. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06641.x · Cited by 68
The role of APP proteolytic processing in lipid metabolism
Grimm, M. O. W., Rothhaar, T. L., & Hartmann, T. (2011) · Experimental Brain Research · doi:10.1007/s00221-011-2975-6 · Cited by 70
Segatto, M., Leboffe, L., Trapani, L., & Pallottini, V. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140303142902 · Cited by 65
Prasanthi, R., Schommer, E., Thomasson, S., Thompson, A. J., Feist, G., & Ghribi, O. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.09.002 · Cited by 67
Regimes of Complex Lipid Bilayer Phases Induced by Cholesterol Concentration in MD Simulation
Pantelopulos, G. A., & Straub, J. E. (2018) · Biophysical Journal · doi:10.1016/j.bpj.2018.10.011 · Cited by 65
Toh, W. H., & Gleeson, P. A. (2016) · Biochemical Journal · doi:10.1042/bcj20160147 · Cited by 62
The Involvement of Lipids in Alzheimer's Disease
Lim, W. L. F., Martins, I. J., & Martins, R. N. (2014) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2014.04.003 · Cited by 67
Hung, Y. H., Robb, E. L., Volitakis, I., Ho, M., Evin, G. M., Li, Q.-X., Culvenor, J. G., Masters, C. L., Cherny, R. A., & Bush, A. I. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.019521 · Cited by 64
BACE: Therapeutic target and potential biomarker for Alzheimer's disease
Evin, G. M., Barakat, A., & Masters, C. L. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.08.017 · Cited by 63
Harris, B., Pereira, I., & Parkin, E. T. (2009) · Brain Research · doi:10.1016/j.brainres.2009.07.105 · Cited by 63
Saito, Y., Sano, Y., Vassar, R. J., Gandy, S., Nakaya, T., Yamamoto, T., & Suzuki, T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801353200 · Cited by 63
Cholesterol and Alzheimer's disease
Wolozin, B. (2002) · Biochemical Society Transactions · doi:10.1042/bst0300525 · Cited by 33
Molecular Dysfunctions of Mitochondria-Associated Membranes (MAMs) in Alzheimer’s Disease
Eysert, F., Kinoshita, P. F., Mary, A., Vaillant-Beuchot, L., Checler, F., & Chami, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249521 · Cited by 63
Košiček, M., Malnar, M., Goate, A., & Hecimovic, S. K. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.007 · Cited by 64
Role of lipid rafts in the processing of the pathogenic prion and Alzheimer's amyloid-β proteins
Taylor, D. R., & Hooper, N. M. (2007) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2007.07.008 · Cited by 61
Self-citationPAR-4 Is Involved in Regulation of β-Secretase Cleavage of the Alzheimer Amyloid Precursor Protein
Xie, J., & Guo, Q. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411933200 · Cited by 61
Altered Distribution of the Gangliosides GM1 and GM2 in Alzheimer’s Disease
Pernber, Z., Blennow, K., Bogdanović, N., Månsson, J., & Blomqvist, M. (2012) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000338181 · Cited by 60
Ahmed, H., Wang, Y., Griffiths, W. J., Levey, A. I., Pikuleva, I. A., Liang, S. H., & Haider, A. (2024) · Brain · doi:10.1093/brain/awae028 · Cited by 61
Alzheimer's Disease and Diabetes: New Insights and Unifying Therapies
Vignini, A., Giulietti, A., Nanetti, L., Raffaelli, F., Giusti, L., Mazzanti, L., & Provinciali, L. (2013) · Current Diabetes Reviews · doi:10.2174/1573399811309030003 · Cited by 57
Bannas, P., Adriouch, S., Kahl, S., Braasch, F., Haag, F., & Koch‐Nolte, F. (2005) · Blood · doi:10.1182/blood-2004-08-3325 · Cited by 57
Fu, Y., Hsiao, J.-H. T., Paxinos, G., Halliday, G. M., & Kim, W. S. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141320 · Cited by 58
Hama, E., Shirotani, K., Iwata, N., & Saido, T. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401891200 · Cited by 56
The Normal and Pathologic Roles of the Alzheimer's β-secretase, BACE1
Kandalepas, P. C., & Vassar, R. J. (2014) · Current Alzheimer Research · doi:10.2174/1567205011666140604122059 · Cited by 56
Grimm, M. O. W., Grösgen, S., Rothhaar, T. L., Burg, V. K., Hundsdörfer, B., Haupenthal, V. J., Frieß, P., Müller, U., Fassbender, K. C., Riemenschneider, M. J., et al. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/695413 · Cited by 55
Amyloid beta-protein and lipid metabolism
Zinser, E. G., Hartmann, T., & Grimm, M. O. W. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.02.014 · Cited by 55
Shrivastava-Ranjan, P., Faúndez, V., Fang, G., Rees, H. D., Lah, J. J., Levey, A. I., & Kahn, R. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-05-0465 · Cited by 54
Dietary lipids and their oxidized products in Alzheimer's disease
Corsinovi, L., Biasi, F., Poli, G., Leonarduzzi, G., & Isaia, G. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100208 · Cited by 54
Cho, Y. Y., Kwon, O.-H., Park, M. K., Kim, T.-W., & Chung, S. (2019) · PLOS ONE · doi:10.1371/journal.pone.0210535 · Cited by 48
Targeting protein palmitoylation: selective inhibitors and implications in disease
Chavda, B., Arnott, J. A., & Planey, S. L. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.933802 · Cited by 55
Geekiyanage, H., Upadhye, A., & Chan, C. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.02.001 · Cited by 52
Pathogenic mechanisms in Alzheimer's disease
Pastorino, L., & Lu, K. P. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.06.078 · Cited by 52
Stockley, J. H., Ravid, R., & O’Neill, C. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.10.076 · Cited by 50
Preferred Endocytosis of Amyloid Precursor Protein from Cholesterol-Enriched Lipid Raft Microdomains
Cho, Y. Y., Kwon, O.-H., & Chung, S. (2020) · Molecules · doi:10.3390/molecules25235490 · Cited by 51
Lipid mediators in membrane rafts are important determinants of human health and disease
David, W. L. (2007) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h07-036 · Cited by 50
Wolozin, B. L., Brown, J. A., Theisler, C. M., & Silberman, S. (2004) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2004.tb00009.x · Cited by 49
Tate, B. A., & Mathews, P. M. (2006) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2006.10.re2 · Cited by 48
Rudajev, V., & Novotný, J. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01127-y · Cited by 52
Membrane Biophysics and Mechanics in Alzheimer's Disease
Yang, X., Askarova, S., & Lee, J. C. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8121-9 · Cited by 49
Lipidomic Profiles in Diabetes and Dementia
Huynh, K., Martins, R. N., & Meikle, P. J. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161215 · Cited by 47
Membrane targeting, shedding and protein interactions of brain acetylcholinesterase
Hicks, D. A., John, D., Makova, N. Z., Henderson, Z., Nalivaeva, N. N., & Turner, A. J. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07032.x · Cited by 47
Self-citationAlzheimer's disease: brain expression of a metabolic disorder?
Merlo, S., Spampinato, S. F., Canonico, P. L., Copani, A., & Sortino, M. A. (2010) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2010.05.005 · Cited by 50
Michaki, V., Guix, F. X., Vennekens, K., Munck, S., Dingwall, C., Davis, J. B., Townsend, D. M., Tew, K. D., Feiguin, F. M., Strooper, B. D., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.288258 · Cited by 48
Self-citationCellular Membrane Fluidity in Amyloid Precursor Protein Processing
Yang, X., Sun, G. Y., Eckert, G. P., & Lee, J. C. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8652-6 · Cited by 49
Motoki, K., Kume, H., Oda, A., Tamaoka, A., Hosaka, A., Kametani, F., & Araki, W. (2012) · Brain and Behavior · doi:10.1002/brb3.52 · Cited by 47
Khalil, A., Berrougui, H., Pawelec, G., & Fülöp, T. (2011) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2011.11.008 · Cited by 46
Kojro, E., Füger, P., Prinzen, C., Kanarek, A. M., Rat, D., Endres, K., Fahrenholz, F., & Postina, R. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-091621 · Cited by 49
Altered membrane fluidity and lipid raft composition in presenilin-deficient cells
Grimm, M. O. W., Tschäpe, J., Grimm, H. S., Zinser, E. G., & Hartmann, T. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00682.x · Cited by 45
Garner, A. E., Smith, D. A., & Hooper, N. M. (2007) · Molecular Membrane Biology · doi:10.1080/09687860601127770 · Cited by 44
Self-citationZhao, B., Shang, S., Li, P., Chen, C., Dang, L., Jiang, Y., Wang, J., Huo, K., Deng, M., Wang, J., et al. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-018-0956-5 · Cited by 44
Rational heterodoxy: Cholesterol reformation of the amyloid doctrine
Castello, M. A., & Soriano, S. (2012) · Ageing Research Reviews · doi:10.1016/j.arr.2012.06.007 · Cited by 45
Statins: The Role in the Treatment and Prevention of Alzheimer's Neurodegeneration
Pac-Soo, C., Lloyd, D. G., Vizcaychipi, M. P., & Ma, D. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110524 · Cited by 42
Koch‐Nolte, F., Adriouch, S., Bannas, P., Krebs, C. F., Scheuplein, F., Séman, M., & Haag, F. (2006) · Annals of Medicine · doi:10.1080/07853890600655499 · Cited by 42
Igbavboa, U., Eckert, G. P., Malo, T. M., Studniski, A. E., Johnson, L. N. A., Yamamoto, N., Kobayashi, M., Fujita, S. C., Appel, T. R., Müller, W. E., et al. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.11.037 · Cited by 41
Alterations in phosphatidylethanolamine levels affect the generation of Aβ
Nesic, I., Guix, F. X., Vennekens, K., Michaki, V., Veldhoven, P. P. V., Feiguin, F. M., Strooper, B. D., Dotti, C. G., & Wahle, T. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00760.x · Cited by 41
Cholesterol and Lipid Rafts in the Biogenesis of Amyloid-β Protein and Alzheimer's Disease
Pantelopulos, G. A., Abraham, C. B., & Straub, J. E. (2024) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-062823-023436 · Cited by 43
Update on lipid membrane microdomains
Schmitz, G., & Grandl, M. (2008) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3282f44c2c · Cited by 39
Calcium Currents Are Enhanced by α2δ-1 Lacking Its Membrane Anchor
Kadurin, I., Alvarez‐Laviada, A., Ng, J., Walker‐Gray, R., D’Arco, M., Fadel, M. G., Pratt, W. S., & DOLPHIN, A. C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.378554 · Cited by 39
Metadata
- Authors
- Cordy, J. M., Hussain, I., Dingwall, C., Hooper, N. M., & Turner, A. J.
- Affiliations
- University of Leeds (GB)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2003-09-22
- Volume
- 100
- Issue
- 20
- Pages
- 11735-11740
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC208827
- OpenAlex
- W2160524771
- Cited by
- 356
- References
- 36
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 7 · 2023: 6 · 2022: 8 · 2021: 7 · 2020: 10 · 2019: 4 · 2018: 5 · 2017: 10 · 2016: 9 · 2015: 5 · 2014: 12 · 2013: 16 · 2012: 30
- FWCI
- 12.29
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Lipid Membrane Structure and Behavior
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Keywords
- beta-secretase, BACE, amyloid precursor protein, lipid rafts, GPI anchoring, amyloid-beta production, APP processing, cholesterol depletion, APP isoforms, Alzheimer's disease, SH-SY5Y cells
- MeSH terms
- Amino Acid Sequence, Cholesterol, Humans, Hydrolysis, Molecular Sequence Data, Endopeptidases, Protein Processing, Post-Translational, Tumor Cells, Cultured, Aspartic Acid Endopeptidases, Amyloid beta-Protein Precursor, Glycosylphosphatidylinositols, Lipid Metabolism, Amyloid Precursor Protein Secretases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review